Krka revenue up 10% to record EUR 1.7bn in 2022, net profit at EUR 361m

Novo Mesto, 26 January - Pharma group Krka reported on Thursday a 10% revenue increase in 2022 to EUR 1.7 billion, the highest figure to date. Sales increased in the majority of Krka's key markets and in all product and service segments. Net profit rose by 17% to EUR 361 million, show the unaudited results.